Psych-STRATA Raises Project Visibility at ECNP Congress 2026
Psych-STRATA project partners attended the 39th European College of Neuropsychopharmacology (ECNP) Congress. Held from 10 to 13 October 2026 in Munich, Germany. The congress brought together researchers, clinicians and mental health professionals from across Europe and beyond. They discussed recent developments in neuroscience, psychiatry and mental health treatment. Connecting Research and Clinical Practice at ECNP […]
Psych-STRATA Holds 5th General Assembly Meeting in Berlin
The Psych-STRATA consortium gathered in Berlin, Germany, on 20–21 April 2026 for its 5th General Assembly Meeting. Partners from across Europe met to review progress, exchange expertise, and plan the next phase of the project. The meeting was hosted by Charité – Universitätsmedizin Berlin Reviewing progress across work packages The meeting opened with an overview […]
Psych-STRATA at the EPA Congress 2026: Strengthening Collaboration and Visibility
Psych-STRATA’s presence at the EPA Congress provided an important opportunity to showcase the project’s work on advancing stratified pharmacogenomics in severe mental illness, as well as to contribute to broader discussions on personalised approaches to mental health care. Beyond dissemination, the event also served as a valuable moment for collaboration. With partners attending from across […]
Psych-STRATA Showcases Patient-Centred Mental Health Innovation at the World Congress of Psychiatry 2025
The Psych-STRATA project was highlighted at the World Congress of Psychiatry (WCP 2025), held in Prague from 5 to 8 October. Work Package 6 co-leader Erik Van der Eycken (GAMIAN-Europe) represented the consortium, bringing the project’s patient-centred vision to an international audience of clinicians, researchers, and mental health advocates. As part of the session “No […]
